Hence, further investigation of PGAM5 may lead to new therapeutic targets and a better understanding of diseases characterized by mitochondrial dysfunction and ROS-mediated cellular necroptosis, including ischemic cardiovascular/myocardial infarction and cerebrovascular/stroke and, potentially, neurodegenerative disorders such as Parkinson’s disease. Here, PGAM5 is linked to Parkinson disease.